Trial Profile
A Phase I Single Dose, Open Label, Randomized, Three Period Crossover Pilot Study to Compare the Pharmacokinetics, Safety and Tolerability of MVP005 Intranasal Spray With Intranasal Administration of Naloxone Solution for Injection in Healthy Adult Subjects
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- 13 Aug 2015 New trial record